HDL and kidney injury after surgery

January 18, 2018 by Jenelle Grewell, Vanderbilt University

Higher concentrations of high-density lipoproteins—HDL, the "good" cholesterol—may be protective against acute kidney injury (AKI) after cardiac surgery, Vanderbilt researchers have discovered. AKI affects up to 30 percent of patients after cardiac surgery.

Loren Smith, MD, Ph.D., and colleagues evaluated 391 patients participating in a of a statin drug to reduce AKI after . They found that a higher preoperative HDL concentration was associated with decreased postoperative creatinine change (a measure of kidney function). The association was strongest in patients who were long-term statin users and was further enhanced in patients who had perioperative statin treatment.

The findings, reported in the Journal of the American Heart Association, identify HDL as a potentially modifiable risk factor for postoperative AKI. The researchers stress, however, that perioperative statins have not prevented AKI in three randomized clinical trials and that other agents which improve HDL function are needed.

Explore further: High-dose statin before, after cardiac surgery does not reduce risk of kidney injury

More information: Loren E. Smith et al. High‐Density Lipoprotein Cholesterol Concentration and Acute Kidney Injury After Cardiac Surgery, Journal of the American Heart Association (2017). DOI: 10.1161/JAHA.117.006975

Related Stories

High-dose statin before, after cardiac surgery does not reduce risk of kidney injury

February 23, 2016
Among patients undergoing cardiac surgery, high-dose treatment with atorvastatin before and after surgery did not reduce the overall risk of acute kidney injury compared with placebo, according to study published by JAMA. ...

High-dose statin may protect heart surgery patients' kidney health

January 20, 2015
Acute kidney injury often arises after major surgery because the kidneys can be deprived of normal blood flow during the procedure. The use of contrast media, or dyes, can contribute to this problem.

No statins before heart surgery, study suggests

May 5, 2016
(HealthDay)—Taking cholesterol-lowering statins right before heart surgery, once touted as a way to prevent common postoperative complications, has no benefit and may even cause harm, a new study suggests.

Pre-op patterns can predict post-cardiac surgery constipation

July 15, 2016
(HealthDay)—For patients undergoing cardiac surgery, preoperative constipation patterns are associated with postoperative constipation patterns, according to a study published online July 12 in the Journal of Clinical Nursing.

Lipophilic tops hydrophilic statins for heart failure

November 6, 2015
(HealthDay)—For patients with heart failure, lipophilic statin is superior to hydrophilic statin for cardiac function and inflammation, according to a meta-analysis published in the December issue of Cardiovascular Therapeutics.

Statins may protect against kidney complications following elective surgery

April 11, 2011
Taking a statin before having major elective surgery reduces potentially serious kidney complications, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN).

Recommended for you

Eating yogurt may reduce cardiovascular disease risk

February 15, 2018
A new study in the American Journal of Hypertension, published by Oxford University Press, suggests that higher yogurt intake is associated with lower cardiovascular disease risk among hypertensive men and women.

Newly discovered gene may protect against heart disease

February 14, 2018
Scientists have identified a gene that may play a protective role in preventing heart disease. Their research revealed that the gene, called MeXis, acts within key cells inside clogged arteries to help remove excess cholesterol ...

Blood thinners may raise stroke risk in over-65s with kidney disease

February 14, 2018
People over 65 years old may be increasing their stroke risk by taking anticoagulants for an irregular heartbeat if they also have chronic kidney disease, finds a new study led by UCL, St George's, University of London and ...

Cardiac macrophages found to contribute to a currently untreatable type of heart failure

February 14, 2018
A team of Massachusetts General Hospital (MGH) investigators has discovered, for the first time, that the immune cells called macrophages contribute to a type of heart failure for which there currently is no effective treatment. ...

Study maps molecular mechanisms crucial for new approach to heart disease therapy

February 13, 2018
Creating new healthy heart muscle cells within a patient's own ailing heart. This is how scientists hope to reverse heart disease one day. Today, a new study led by UNC-Chapel Hill researchers reveals key molecular details ...

Quality toolkit improves care in Indian hospitals

February 13, 2018
A simple toolkit of checklists, education materials and quality and performance reporting improved the quality of care but not outcomes in hospitals in the south Indian state of Kerala and may have the potential to improve ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.